Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
2017 | ImMAGE Biotherapeutics Announces Termination of Operations | CI |
2017 | ImMAGE Biotherapeutics Initiates Repeat Toxicology Study for Lead Candidate, IMT-001 | CI |
Business Summary
Number of employees: 4
Sales per Business
USD in Million | 2016 | Weight | Delta |
---|---|---|---|
Cancer Immunotherapy
nan
%
| 0 | nan % | - |
Sales per region
USD in Million | 2016 | Weight | Delta |
---|---|---|---|
United States
nan
%
| 0 | nan % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mahesh Narayanan
FOU | Founder | 35 | 21/12/21 |
Anton Dormer
FOU | Founder | 60 | 21/12/21 |
Zhi Cong Mou
CEO | Chief Executive Officer | 41 | - |
Elton Norman
DFI | Director of Finance/CFO | 61 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Zhi Cong Mou
CEO | Chief Executive Officer | 41 | - |
Elton Norman
DFI | Director of Finance/CFO | 61 | - |
Anton Dormer
FOU | Founder | 60 | 21/12/21 |
Mahesh Narayanan
FOU | Founder | 35 | 21/12/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 151,744,566 | 45,742,136 ( 30.14 %) | 0 | 30.14 % |
Company contact information
Immage Biotherapeutics Corp.
10411 Motor City Drive Suite 750
20817, Bethesda
+866 692 2939
1st Jan change | Capi. | |
---|---|---|
-.--% | 151 | |
+5.92% | 11TCr | |
-4.43% | 6.38TCr | |
+60.48% | 4.53TCr | |
+16.73% | 3.89TCr | |
+6.77% | 3.31TCr | |
+12.31% | 2.02TCr | |
+13.41% | 1.69TCr | |
+25.44% | 1.61TCr | |
+5.80% | 1.45TCr |
- Stock Market
- Equities
- IMMG Stock
- Company Immage Biotherapeutics Corp.